-
FEATURED CONTENT
Overview
Incidental findings are abnormalities uncovered unintentionally and often unrelated to the condition that prompted an exam. Pulmonary nodules are abnormal growths that form in a lung. They can be identified on imaging scans, such as X-ray and computed tomography (CT) scans.
Most pulmonary nodules are benign, but some can indicate the presence of lung cancer. Incidental pulmonary nodule (IPN) findings may allow more patients with lung cancer to be diagnosed at earlier stages. Detecting lung cancer at an early stage may help improve prognosis. But there are many barriers in the way of patients receiving the care they need. We’ve outlined the top needs and challenges along the IPN patient journey here.
The Lung Ambition Alliance, a global coalition with partners across disciplines in over 50 countries, was formed to combat lung cancer through accelerating innovation and driving forward meaningful improvements for people with lung cancer. We do this by advocating for improved approaches in three areas: screening and early diagnosis, accelerated delivery of innovative medicine, and improved quality care.
This report is sponsored by AstraZeneca, an Advisory Board member organization. Representatives of AstraZeneca helped select the topics and issues addressed. Advisory Board experts wrote the report, maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.
To learn more, view our editorial guidelines.
This report is sponsored by AstraZeneca, in partnership with The Lung Ambition Alliance. Advisory Board experts wrote the report, conducting the underlying research independently and objectively. AstraZeneca had the opportunity to review the report.
Learn more
Posted on January 27, 2023
Updated on October 30, 2023
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
You've reached your limit of free insights
